TRUFFLE CAPITAL, BUSINESS BUILDERS
For 20 years, Truffle Capital has been building companies, financing innovation, developing and supporting pioneering technologies in the fields of biomedtech and fintech
Truffle at a Glance
For more than two decades, Truffle Capital has been a leading independent European Business Builder, at the forefront of creating, financing and nurturing innovation, playing a pivotal role in the growth and empowerment of technology leaders in two fields of expertise: Life Sciences (MedTech & Biotech) and Deeptech applied to Finance (Fintech & Insurtech).
Truffle Capital's mission is to drive the creation and development of companies on their journey to becoming tomorrow's leaders in BioMedTech and Finance/Insurance. Led by its two co-founders and CEOs, Philippe Pouletty, M.D. and Bernard-Louis Roques, Truffle Capital has €500M AuM, raising more than €1.2 Bn since its creation and supporting more than tens of companies with numerous successful exits. In line with its DNA, Truffle acts as a founder systematically in BioMedTech, a lead investor in financing rounds and is proactive in governance.
Our Key Figures
2001
Creation of Truffle Capital
€ 1.2Bn
Raised
€ 500M
AUM
28
Active portfolio companies
46
Exits
15
IPOs
Our Governance
Philippe Pouletty, M.D.
CEO and Co-Founder
- Founder of Abivax, Founder of Carvolix and others
- Inventor of 39 patents
- Serial entrepreneur
- Major in immunology at the Pasteur Institute
- Member of the Stanford Inventor Hall of Fame
Henri Moulard
Chairman & Co-Founder
- Chairman & CEO of Generali
- Chairman of Banque Neuflize, ABN Amro France
- Officer of the Légion d'Honneur
LATEST NEWS
